Search

everythinglearnresearchcommunity

for

Search:↓

Ashwagandha nanoparticles help hair grow by increasing a growth factor.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

A new topical method using peptides boosts hair growth effectively with less finasteride and fewer side effects.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

HSA nanoparticles can improve tamoxifen delivery for breast cancer treatment, reducing side effects.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

Ethosomes are a promising way to deliver drugs through the skin.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

The Engrailed-1 gene plays a key role in the development of sweat glands in mice.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.